Letter From The Editor

I have recently been cycling with some insulin pump patients, and they often complain about their problems with fluctuating glucose levels, before, during, and after they ride. We have tried many fixes and changes to see if we can control the fluctuations, but there does not seem to be a …

If you are like me, it seems like the number of emails that we get has jumped up. Often this increase in emails causes me to miss important ones, while I try to deletae all the spam that constantly appears. We at Diabetes in Control want to do our part …

I was talking to Ashley Ball, PharmD Candidate, LECOM-School of Pharmacy, about the problem with helping patients with DPN. We were talking about how you can definitively say the pain is really DPN, and not something else like arthritis. She decided to see what kind of tests were available and …

Today I had 8 Doctor of Pharmacy Candidates on a Teams call to talk about diabetes medications. The goal was to take these students from classroom recitation of information to the real world, where they have to explain things to patients, not professors. As you can guess there was a …

How many of our patients change their oil as soon as the change oil light comes on, or rotate and balance their tires when the maintenance schedule calls for it? Based on a few emails I sent out, almost everyone does. They feel that that preventative care can save them …

Over the past 20 years, we have seen many different solutions offered for type 2 diabetes and prediabetes. It seems that any time you give patients extra education and extra finances for food choices, the results are positive. But what happens when that help is no longer there? The answer …

Many patients that wear a continuous glucose sensor also use pump therapy. This means at any time they have 2 injection sites in use on their body, and those sites are more often than not in the abdominal area. If the patient is a new user it is not a …

Luseogliflozin is an SGLT-2 inhibitor that has been available since 2014 in Japan, but has never been released in the US. Based on a study that our intern, Torré Anderson, II, Fourth Year Doctor of Pharmacy Candidate, Florida A&M University College of Pharmacy, has for us this week, it may …

There has been a lot of clamor over the introduction of Wegovy for weight loss. The GLP-1 mimetic had such a huge introduction that supply was not able to keep up with demand. This is a double strength Ozempic product and looks to help patients with obesity as well as …

One thing about having virtual conferences is that you can easily measure the attendance of any presentation; live and revisited. This year the most viewed presentation was from our own Diabetes and Physical Activity expert, Dr. Sheri Colberg. Dr. Colberg delivered a program on the differences between low and high …